Cardiovascular effects produced by bradykinin microinjection into the nucleus tractus solitarii of anesthetized rats

Brain Research

Volumn 720, Issue 1-2, 1996, Pages 183-190

  Caligiorne, Sordaini M ^a   Santos, Robson A S ^a   Campagnole Santos, Maria J ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Baroreceptor control of heart rate; Baroreflex; Blood pressure; Bradykinin; Bradykinin antagonist; HOE 140; Nucleus tractus solitarius (nTS)

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR; ICATIBANT; METHYLATROPINE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART RATE; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS;

EID: 0029890633     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01498-5     Document Type: Article

References (40)

1. Angaut-Petit, D., The dorsal column system. II. Functional properties and bulbar relay of the post-synaptic fibers of the cat's fascicularis gracilis, Exp. Brain Res., 22 (1975) 471-493.
2. Bao, G., Gohlke, P., Qadri, F. and Unger, T., Chronic kinin receptor attenuates the antihypertensive effects of ramipril, Hypertension, 20 (1992) 74-79.
3. Berecek, K.H., Okuno, T., Nagahama, S. and Oparil, S., Altered vascular reactivity and baroreflex sensitivity induced by chronic by central administration of captopril in the spontaneously hypertensive rat, Hypertension, 5 (1983) 689-700.
4. Braas, K.M., Manning, D.C., Perry, D.C. and Snyder, S.H., Bradykinin analogues: differential agonist and anlagonist activities suggesting multiple receptors, Br. J. Pharmacol, 94 (1988) 3-5.
5. Bhoola, K.D., Figueroa, C.D. and Worthy, K., Bioregulation of kinins: kallikreins, kininogens, and kininases, Pharmacol. Rev., 44 (1992) 1-80.
6. Bonica, J.J., Anatomic and physiologic basis of nociception and pain. In: J.J. Bonica (Ed.), The Management of Pain, Vol. 1, Malvern, Pennsylvania, 1990, pp. 28-94.
7. Cachofeiro, V., Sakakibara, T. and Nasjletti, A., Kinins, nitric oxide, and the hypertensive effect of captopril and ramiprilat in hypertension, Hypertension, 19 (1992) 138-145.
8. Campagnole-Santos, M.J., Diz, D., Santos, R.A.S., Khosla, M.C., Brosnihan, K.B. and Ferrario, C.M., Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats, Am. J. Physiol., 257 (1989) H324-H329.
9. Casto, R. and Phillips, M.I., Mechanisms of pressor effects by angiotensin in the nucleus tractus solitarius of rats, Am. J. Physiol., 257 (1984) R575-R581.
10. Correa, F.M.A. and Graef, F.G., Central site of the hypertension action of bradykinin, J. Pharmacol. Exp. Ther., 192 (1975) 670-676.
11. Diz, D., Bradykinin and related peptides in central control of the cardiovascular system, Peptides, 6 (Suppl. 2) (1985) 57-64.
12. Diz, D. and Jacobowits, D.M., Cardiovascular effects of discrete intrahypothalamic and preoptic injections of bradykinin, Brain Res. Bull., 12 (1984) 409-417.
13. Erdös, E.G. and Skidgel, R.A., The angiotensin I-converting enzyme (editorial), Lab. Invest., 56 (1987) 345-348.
14. Farmer, S.G., Burch, R.M., Mfeker, S.A. and Wilkins, D.A., Evidence for a pulmonary B3 bradykinin receptor, Mol. Pharmacol., 36 (1989) 1-8.
15. Fior, D.R., Martins, D.T.O. and Lindsey, C.J., Localization of central pressor action of bradykinin in medulla oblongata, Am. J. Physiol., 265 (1993) H1000-H1006
16. 2 subtypes, Life Sci., 44 (1989) 1645-1653.
17. Gerken, V. and Santos R.A.S., Centrally infused bradykinin increased baroreflex sensitivity. Hypertension, 19 (Suppl. II) (1992) II-176-II-181
18. Gibson, B.E., Oliver, S.B., Maass, L. and Cucchiara, R.F., Esmolol for the control of hypertension following neurologic surgery, Anesth. Analg., 67 (1988) S71.
19. Lewis, R.E. and Phillips, M.I., Localization of the central pressor action of bradykinin to the cerebral third ventricle, Am. J. Physiol., 246 (1984) R63-R68.
20. Madeddu, P., Glorioso, N., Soro, A., Tonolo, G., Manunta, P., Troffa, C., Demontis, M.P. and Anania, V., Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats. Hypertension, 15 (1990) 407-412.
21. Madeddu, P., Glorioso, N., Varoni, M.V., Demontis, M.P., Fattaccio, M.C. and Anania, V., Cardiovascular effects of brain kinin receptor blockade in spontaneously hypertensive rats, Hypertension, 23 (Suppl. I) (1994) I-189-1-192.
22. Madeddu, P., Anania, V., Glorioso, N., Chao, L. and Chao, J., Role of the brain kallikrein-kinin system in the pathogenesis of genetic hypertension, Proceedings of the First European Congress of Pharmacology, Abstract book, 1995, p. 29.
23. Maggi, C.A. and Melli, A., Suitability of urethane anesthesia for physiopharmacology investigation in various systems. Part 2. Cardiovascular system, Experientia, 40 (1986) 51-59.
24. Muzzi, D.A., Black, S., Losasso, T.J. and Cucchiara, R.F., Labetalol and esmolol in the control of hypertension after intracranial surgery, Anesth. Analg., 70 (1990) 68-71.
25. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, Australia, 1986.
26. 125I]bradykinin binding sites in guinea pig brain, Brain Res., 577 (1991) 73-79.
27. Privitera, P.J., Thibodeaux, H. and Yates, P., Rostral ventrolateral medulla as a site for the central hypertensive action of kinin, Hypertension, 23 (1994) 52-58.
28. Porembka, D., Ebrahim, Z., Bloomfield, E. and Stuebing, R., The postoperative hyperdynamic cardiovascular response following intracranial excision of arterial venous malformation (AVM), Anesthesiology, 75 (1991) A215.
29. Pruneau, D., Duvoid, A., Luccarini, J.M., Belichard, P. and Bonnafous, J.C., The kinin B-1 receptor antagonist Des-Arg(9)-[leu(8)] Bradykinin: an antagonist of the angiotensin AT(1) receptor which also binds to the AT(2) receptor, Br. J. Pharmacol., 114 (1995) 115-118.
30. Regoli, D., Mareau, F. and Lavigne, J., Induction of B1 receptors for kinin in the rabbit by a bacterial lipopolysaccharide, Eur. J. Pharmacol., 71 (1981) 105-115.
31. Regoli, D., Rhaleb, N.E., Drapeau, G. and Dion, S., Kinin receptor subtypes, J. Cardiovasc. Pharmacol., 15 (1990) S30-S38.
32. Rettig, R., Healy, D.P. and Printz, M.P., Cardiovascular effects of microinjections of angiotensin II into the nucleus tactus solitarii, Brain Res., 364 (1986) 233-240.
33. Roberts, R.A., Bradykinin receptors: characterization distribution and mechanisms of signal transduction, Prog. Growth Factors Res., 1 (1989) 237-252.
34. Salgado, M.C.O. and Krieger, E.M., Hyperreactivity to bradykinin and alterations in angiotensin I conversion and bradykinin inactivation in renal hypertensive rats, Hypertension, 4 (1982) 77-83.
35. Santos, R.A.S., Brosnihan, K.B., Chapell, M.C., Pesquero, J., Chernicky, C.L., Greene, L.J. and Ferrario, C.M., Converting enzyme activity and angiotensin metabolism in the dog brain stem, Hypertension, 11 (Suppl. I) (1988) I-153-I-157.
36. Scicli, A.G. and Carretero, A.O., The brain kallikrein-kinin system. A possible role in blood pressure regulation, Hypertension, 15 (1990) 413-414.
37. Snider, R.M. and Richelson, E., Bradykinin receptor mediated cyclic GMP formation in a nerve cell population (murine neuroblastoma, clone NIE-115), J. Neurochem., 43 (1984) 1749-1754.
38. Spyer, K.M., The central nervous organization of reflex circulatory control. In: A.D. Loewy and K.M. Spyer (Eds.), Central Regulation of Autonomie Functions, Oxford University Press, New York, 1990, pp. 168-188.
39. Sumitani, M., Vilas-Boas, W.W., Capdevile, R.C., Campagnole-Santos, M.J., Krieger, E.M. and Santos, R.A.S., Selective reversal of the impaired bradycardic component of the baroreflex after blockade of the renin-angiotensin system in renal hypertensive rats (abstract), Hypertension, 9 (1987) 536.
40. Wirth, K., Hock, F.J., Albus, U., Alpermann, H.G., Anagnostopoulos, H., Henke, St., Breipohl, G., König, W., Knolle, J. and Schölkens, B.A., Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies, Br. J. Pharmacol., 102 (1991) 774-777.